Design Therapeutics Inc (DSGN)

Finanzdaten der Design Therapeutics Inc-Aktie (DSGN)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
	12.54%22.18	19.71	18.17	19.31	21.57
Research and Development	13.97%16.39	14.38	13.43	14.59	15.74
Operating Income/Loss	12.54%-22.18	-19.71	-18.17	-19.31	-21.57
	14.34%-20.17	-17.64	-16.00	-17.00	-19.08
Attributable To Parent	14.34%-20.17	-17.64	-16.00	-17.00	-19.08
Basic Average Shares	1.74%62.51	61.43	0.47	56.95	56.86
Diluted Average Shares	1.74%62.51	61.43	0.47	56.95	56.86
Basic Earnings Per Share	10.34%-0.32	-0.29	-0.27	-0.30	-0.34
Diluted Earnings Per Share	10.34%-0.32	-0.29	-0.27	-0.30	-0.34